Showing results (41-50 of 237) with videos related to
Sort By:
Pageof 24
The American Journal of Gastroenterology|May 13, 2021
Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese IndividualsGen Yamada, Yasuhiro Hagiwara, Takeshi Kimura, et al.Biological & Pharmaceutical Bulletin|June 7, 2006
Sequence analysis of chloroplast chlB gene of medicinal Ephedra species and its application to authentication of Ephedra HerbYahong Guo, Ayako Tsuruga, Shigeharu Yamaguchi, et al.Photodiagnosis and Photodynamic Therapy|May 2, 2026
Cost-effectiveness analysis of transurethral resection of bladder tumor with photodynamic diagnosis with 5-aminolevulinic acid hydrochloride for non-muscle invasive bladder cancerTaikei Akiyama, Hideo Fukuhara, Yasuhiro Hagiwara, et al.Japanese Journal of Clinical Oncology|December 15, 2011
FOLFIRI plus bevacizumab 5 mg/kg versus 10 mg/kg as second-line therapy in patients with metastatic colorectal cancer who have failed first-line bevacizumab plus oxaliplatin-based therapy: a randomized phase III study (EAGLE Study)Hideyuki Mishima, Koji Oba, Junichi Sakamoto, et al.Influenza and Other Respiratory Viruses|August 20, 2013
Comparison of the clinical effectiveness of zanamivir and laninamivir octanoate for children with influenza A(H3N2) and B in the 2011-2012 seasonNaoko Koseki, Miki Kaiho, Hideaki Kikuta, et al.Japanese Journal of Clinical Oncology|January 19, 2008
A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study groupHaruhiko Cho, Akira Tsuburaya, Junichi Sakamoto, et al.Japanese Journal of Clinical Oncology|September 8, 2010
Multicentre phase II study of XELOX with bevacizumab in late-stage elderly patients with unresectable advanced/recurrent colorectal cancer: an ASCA studyKoji Oba, Masaki Matsuoka, Taroh Satoh, et al.Diseases of the Colon and Rectum|July 19, 2019
Development and Validation of a Prediction Model for Organ-Specific Recurrences After Curative Resection of Colon CancerHiroshi Nagata, Soichiro Ishihara, Koji Oba, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|March 14, 2009
Effects of cardiac complications on cardiovascular events in Japanese high-risk hypertensive patients: subanalysis of the CASE-J trialKenji Ueshima, Shinji Yasuno, Koji Oba, et al.Cancer Immunology, Immunotherapy : CII|September 1, 2005
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trialsJunichi Sakamoto, Satoshi Morita, Koji Oba, et al.Pageof 24